The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Mirabegron Clonmel 50 mg prolonged-release tablets



Clonmel Healthcare LtdPA0126/396/001

Main Information

Trade NameMirabegron Clonmel 50 mg prolonged-release tablets
Active SubstancesMirabegron
Dosage FormProlonged-release tablet
Licence HolderClonmel Healthcare Ltd
Licence NumberPA0126/396/001

Group Information

ATC CodeG04BD12 mirabegron

Status

License statusAuthorised
Licence Issued06/09/2024
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusNot applicable
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back